XLV holdings and overlap
Health Care Select Sector SPDR Fund (XLV) holds 62 positions in its SPDR file of 2026-10-15. Its three largest are Eli Lilly (LLY) at 15.57%, Johnson & Johnson (JNJ) at 9.49% and AbbVie (ABBV) at 7.79%, and its ten largest make up 60.2% of the fund.
In its SPDR file of 2026-10-15, XLV is 99.7% health care by sector, with none of it in mega-cap tech or in the ten largest US companies by market value.
What does XLV hold, as of its issuer file of 2026-10-15?
Eli Lilly is 15.57% of XLV on its own, against a median largest position of 8.7% across the 28 Health Care funds with a page here. The position XLV carries furthest above that group is Johnson & Johnson at 9.49% of the fund, a company the median fund in that group does not hold at all.
| Rank | Company | Weight | Weight bar |
|---|---|---|---|
| 1 | LLY Eli Lilly | 15.57% | |
| 2 | JNJ Johnson & Johnson | 9.49% | |
| 3 | ABBV AbbVie | 7.79% | |
| 4 | UNH UnitedHealth Group | 5.68% | |
| 5 | MRK Merck | 5.57% | |
| 6 | TMO Thermo Fisher Scientific | 4.01% | |
| 7 | AMGN Amgen | 3.65% | |
| 8 | GILD Gilead Sciences | 3.03% | |
| 9 | ABT Abbott Laboratories | 2.82% | |
| 10 | PFE Pfizer | 2.61% | |
| 11 | ISRG Intuitive Surgical | 2.35% | |
| 12 | DHR Danaher | 2.25% | |
| 13 | VRTX Vertex Pharmaceuticals | 2.01% | |
| 14 | BMY Bristol Myers Squibb | 1.92% | |
| 15 | CVS CVS Health | 1.84% | |
| 16 | MDT Medtronic | 1.82% | |
| 17 | MCK McKesson | 1.81% | |
| 18 | SYK Stryker | 1.59% | |
| 19 | ELV Elevance Health | 1.44% | |
| 20 | MRNA Moderna | 1.37% | |
| 21 | CI Cigna | 1.23% | |
| 22 | REGN Regeneron Pharmaceuticals | 1.21% | |
| 23 | HCA HCA Healthcare | 1.07% | |
| 24 | COR Cencora | 1.01% | |
| 25 | BSX Boston Scientific | 0.99% | |
| 26 | CAH Cardinal Health | 0.92% | |
| 27 | BDX Becton Dickinson | 0.82% | |
| 28 | HUM Humana | 0.81% | |
| 29 | EW Edwards Lifesciences | 0.79% | |
| 30 | A Agilent Technologies | 0.77% | |
| 31 | VEEV Veeva Systems | 0.73% | |
| 32 | IQV IQVIA | 0.69% | |
| 33 | WAT Waters | 0.68% | |
| 34 | IDXX Idexx Laboratories | 0.67% | |
| 35 | ILMN Illumina | 0.63% | |
| 36 | RMD ResMed | 0.54% | |
| 37 | CNC Centene | 0.54% | |
| 38 | BIIB Biogen | 0.54% | |
| 39 | DXCM Dexcom | 0.51% | |
| 40 | MTD Mettler Toledo | 0.51% | |
| 41 | ZTS Zoetis | 0.5% | |
| 42 | GEHC GE HealthCare | 0.49% | |
| 43 | WST West Pharmaceutical Services | 0.42% | |
| 44 | DGX Quest Diagnostics | 0.41% | |
| 45 | LH Labcorp | 0.41% | |
| 46 | STE Steris | 0.34% | |
| 47 | VTRS Viatris | 0.33% | |
| 48 | INCY Incyte | 0.3% | |
| 49 | ZBH Zimmer Biomet | 0.28% | |
| 50 | RVTY Revvity | 0.27% | |
| 51 | CRL Charles River Laboratories | 0.23% | |
| 52 | BAX Baxter International | 0.21% | |
| 53 | SOLV Solventum | 0.2% | |
| 54 | TECH Bio-Techne | 0.18% | |
| 55 | COO Cooper Companies | 0.17% | |
| 56 | ALGN Align Technology | 0.15% | |
| 57 | UHS Universal Health Services | 0.15% | |
| 58 | PODD Insulet | 0.15% | |
| 59 | HSIC Henry Schein | 0.13% | |
| 60 | DVA DaVita | 0.1% | |
| 61 | IXCZ6 Xav Health Care Dec26 | 0.01% | |
| 62 | 2602335D TPG Inc | 0.0% |
The most recent file State Street SPDR has published for XLV is dated 2026-10-15, 1 day before these prices, which is the median for the State Street SPDR ETFs covered here. Every one of the 62 positions XLV holds, with its weight, is in the fund's JSON file. See the other 118 ETFs with a page here that hold LLY, and how their weights compare with the 15.57% XLV gives it.
Category: Health Care, set by TickerInside from the ETF's own latest file. In its file of 2026-10-15, 100% of its stocks whose sector is known are health care companies, each in the sector the site gives that company. How categories are set.
https://tickerinside.com/api/v1/fund/xlv.jsonhttps://tickerinside.com/api/v1/fund/xlv.csv=IMPORTDATA("https://tickerinside.com/api/v1/fund/xlv.csv")If your sheet uses a decimal comma: =IMPORTDATA("https://tickerinside.com/api/v1/fund/xlv.csv"; ","; "en_US")curl -s https://tickerinside.com/api/v1/fund/xlv.jsonHow much money went into or out of XLV?
On the close of Monday, October 12, 2026, $17 million went into XLV, 0.04% of its assets, as it created shares. Over its last 5 closes, a net inflow of $133 million.
From XLV's own holdings files. Every ETF's latest flows.
How is XLV split by sector?
| Sector | Weight | Weight bar |
|---|---|---|
| Health care | 99.7% |
From its SPDR file of 2026-10-15. How these are measured.
What did XLV hold in its SEC reports since 2019?
In XLV's SEC filings, its largest position went from Johnson & Johnson (JNJ) at 10.11% on 2019-09-30 to Lilly (Eli) (LLY) at 16.51% on 2026-06-30, across 28 quarterly reports.
| Report | Positions | Largest | Top 10 |
|---|---|---|---|
| 2019-09-30 | 59 | JNJ 10.11% | 50.2% |
| 2019-12-31 | 58 | JNJ 10.09% | 51.8% |
| 2020-12-31 | 61 | JNJ 9.71% | 50.7% |
| 2021-12-31 | 63 | UNH 8.81% | 51.6% |
| 2022-12-31 | 62 | UNH 9.74% | 55.7% |
| 2023-12-31 | 63 | UNH 9.62% | 54.2% |
| 2024-12-31 | 61 | LLY 12.09% | 57.0% |
| 2025-12-31 | 60 | LLY 15.19% | 58.4% |
| 2026-06-30 | 59 | LLY 16.51% | 61.5% |
The first report, then the last of each year, of the 28 reports XLV filed on SEC Form N-PORT from 2019-09-30 to 2026-06-30, each company under its ticker today. Every position of every report is in its quarterly file, and at any date at /api/v1/history/xlv/{date}.json. How these are read.
What does XLV duplicate?
The ETF nearest to XLV is IYH: the two hold 91.2% of their weight in common, in the 55 companies both own, and 93.9% of XLV itself is also held there. Owning XLV alongside the ETFs at the top of this table means holding mostly the same companies twice.
| ETF | Overlap by weight | Of XLV held there | Of that ETF in XLV | Companies in both | Overlap bar |
|---|---|---|---|---|---|
| IYH | 91.2% | 93.9% | 91.4% | 55 | |
| VHT | 85.5% | 100.0% | 86.0% | 60 | |
| IXJ | 73.7% | 100.0% | 74.0% | 60 | |
| RSPH | 53.4% | 100.0% | 100.0% | 60 | |
| PPH | 38.3% | 46.7% | 58.9% | 10 | |
| PJP | 38.0% | 54.7% | 56.6% | 12 | |
| IHE | 34.9% | 36.1% | 69.8% | 7 | |
| BMED | 34.8% | 53.0% | 69.8% | 22 | |
| CANC | 19.6% | 48.4% | 21.2% | 8 | |
| XT | 19.5% | 61.9% | 19.6% | 18 | |
| VIG | 17.6% | 68.4% | 17.7% | 22 | |
| PFM | 17.5% | 73.0% | 17.5% | 24 |
The holdings of VHT and CANC are from their SEC Form N-PORT filings for the period ended 2026-05-31, filed 2026-07-29. PPH's holdings are from its SEC Form N-PORT for the period ended 2026-06-30, filed 2026-08-26. VIG's holdings are from its SEC Form N-PORT for the period ended 2026-07-31, filed 2026-09-28. The other ETFs' holdings are from their issuers' latest files. Check XLV against any ETF in the ETF overlap calculator · how overlap is measured.
What adds something different to XLV?
SOXX shares 0% of weight with XLV and its weekly returns correlate with it at 0.13 over three years. The table lists the covered ETFs with the least in common with XLV, least shared weight first and, among equals, lowest correlation.
| ETF | Name | Overlap by weight | Correlation, 3y | Companies in both |
|---|---|---|---|---|
| SOXX | iShares Semiconductor ETF | 0.0% | 0.13 | 0 |
| MCHI | iShares MSCI China ETF | 0.0% | 0.16 | 0 |
| PFF | iShares Preferred and Income Securities ETF | 0.0% | 0.27 | 0 |
| PICK | iShares MSCI Global Metals & Mining Producers ETF | 0.0% | 0.33 | 0 |
| SCZ | iShares MSCI EAFE Small-Cap ETF | 0.0% | 0.45 | 0 |
| IJR | iShares Core S&P Small-Cap ETF | 0.0% | 0.48 | 0 |
| IJH | iShares Core S&P Mid-Cap ETF | 0.0% | 0.49 | 0 |
| USRT | iShares Core U.S. REIT ETF | 0.0% | 0.54 | 0 |
Cost, returns and risk
| Expense ratio | 0.08% |
|---|---|
| Dividend yield | 1.52% |
| Total return, 1 year | 25.7% |
| Total return, 3 years cumulative | 45.5% |
| Total return, 5 years cumulative | 46.0% |
| Volatility, annualised | 15.1% |
| Worst fall, 3 years | -16.1% |
| Beta against SPY, 3 years of weekly returns | 0.42 |
| Weight in the ten largest positions | 60.2% |
| Largest single position | 15.6% |
| Assets under management | $43.4B |
Expense ratio, yield and assets are reference data (the expense ratio from XLV's SEC filing of 2026-01-28); the weight in the ten largest positions and the largest single position are from the issuer file of 2026-10-15; every other figure is computed here from weekly closes.
How it moves with the market
| Against | Correlation, 3 years | Covariance, annualised, in percent squared |
|---|---|---|
| SPY | 0.39barely linked | 85 |
| QQQ | 0.21barely linked | 62 |
Weekly total returns. What the bands mean · why the covariance is printed.
Year by year
| Year | Total return |
|---|---|
| 2026 | 15.9% |
| 2025 | 14.5% |
| 2024 | 2.5% |
| 2023 | 2.1% |
| 2022 | -2.1% |
One year
Where to go next
- XPH, State Street SPDR S&P Pharmaceuticals ETF
- ARKG, ARK Genomic Revolution ETF
- BBH, VanEck Biotech ETF
- BMED, iShares Health Innovation Active ETF
- Run a portfolio x-ray to see what XLV carries once you look through it
- Compare XLV against any other ETF in the builder
Holdings from the most recent file State Street SPDR has published, dated 2026-10-15. Prices through 2026-10-16. How every figure here is produced. Measurements, not investment advice.
Cite this page
TickerInside, Health Care Select Sector SPDR Fund (XLV), holdings from the issuer's file of 2026-10-15, https://tickerinside.com/etf/xlv/, CC BY 4.0
<a href="https://tickerinside.com/etf/xlv/">TickerInside</a> (https://tickerinside.com/etf/xlv/)